IRVINE, CA--(Marketwire - Jan 29, 2013) - BIOLASE, Inc. (
Samir Chowdhury, Ph.D., an accomplished senior operations executive, has been appointed General Manager. Dr. Chowdhury will primarily oversee the Company's new product development and engineering efforts as well as assist in developing strategic business plans, creating new lines of business, marketing current leading-edge technologies and establishing new revenue streams. Previously, Dr. Chowdhury held the General Manager and Chief Operating Officer positions at Gamma Medica, Inc., where he managed the Clinical, Pre-Clinical, and Industrial/Space Imaging operations, including sales, marketing, mergers and acquisitions, production, supply chain, engineering, and distribution. Within six years, Gamma Medica's sales grew by five-hundred percent and it generated multi-million dollar revenue. Prior experience includes Senior Principal Research Scientist at Siemens Molecular Imaging and Phillips Medical where he worked in the research and development of new products, eight of which were awarded patents that were introduced throughout global markets. Dr. Chowdhury graduated from the University of Michigan, with a B.S. in Electrical Engineering, and received a M.S. and a Ph.D. in Biomedical Engineering from the University of Akron.
Colleen Boswell, a senior executive with experience in quality and regulatory compliance in high growth medical device companies, has been appointed Vice President, Regulatory Affairs. Ms. Boswell will oversee and execute regulatory compliance initiatives for the Company, providing oversight for all U.S. and international regulatory matters, including filings and interactions with regulatory authorities. Before coming to BIOLASE, Ms. Boswell worked at Sybron Dental Specialties, Inc., a Danaher company, rising throughout her career there to Vice President, Regulatory Affairs. Previously, she worked at Alpha Therapeutic Corporation in the Biological Division. She began her career at the Baxter Healthcare Corporation, Edwards CVS Division. Ms. Boswell graduated from the University of California, Irvine, with a Bachelor of Science in Biological Sciences.
"We are delighted to welcome both Samir Chowdhury and Colleen Boswell to BIOLASE," said Federico Pignatelli, Chairman and CEO. "The addition of these very accomplished individuals to our senior management team -- Dr. Chowdhury, with his considerable achievements in developing and commercializing technology, and Ms. Boswell with her outstanding knowledge of regulatory compliance -- will significantly strengthen BIOLASE's overall operations and help us to continue to grow our core dental product franchise and focus on disciplined and successful execution as we advance our exciting pipeline in the years ahead."
About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate approximately 290 patented and patent-pending technologies designed to provide biological treatment and clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment and CAD/CAM systems. BIOLASE has sold more than 21,000 lasers.
Other products under development address ophthalmology and other medical and consumer markets.
For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolaseinc, Twitter at twitter.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.